Project Grant R34DA061012
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of California, Los Angeles a $376,398 Project Grant effective April 15, 2026, through February 28, 2029, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports the development and preliminary evaluation of a digital therapeutic intervention titled Anxiety Management Treatment for Substance Use Disorders (AMT/SUD), designed to address the clinical gap in treating patients...
- Federal Grant Award Summary Partnership To End Addiction received a $453,750 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate HALO (Helping Affected Loved Ones), an artificial intelligence-powered chatbot designed to provide evidence-based support to concerned significant others (CSOs) of individuals with substance use disorder (SUD). The award, issued on March 15, 2026, with completion...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $2,237,668 to the University of California, San Diego under the Drug Use and Addiction Research Programs (CFDA 93.279) on May 15, 2026, for a project titled "Nothing About Us Without Us: Integrating the Voices of People Who Use Drugs Into HIV Resource Allocation Using Large Language Models." The five-year project, concluding March 31, 2031, will develop an innovative modeling framework that...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of California, Berkeley a $2.37 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on the efficacy and mechanisms of web-based Regulation of Craving Training (ROC-T) for smoking cessation. The project, which commenced September 1, 2025, and extends through May 31, 2030, will deliver a clinical research program evaluating two versions of...
- Federal Grant Award Summary Biomotivate LLC received a $613,744 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a non-invasive digital therapeutic tool for individuals with opioid use disorders (OUDs). Awarded on August 1, 2025, with completion targeted for July 31, 2027, the project delivers a precision medicine...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Columbia University's Health Sciences Division a $581,543 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a clinical trial of the Sense2Quit mobile health application for smoking cessation among people with HIV (PWH). The award, effective April 15, 2026 through February 28, 2031, supports the development and evaluation of an innovative sensor-enabled smartphone intervention...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded $651,468 to the University of Texas at Austin on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop, evaluate, and disseminate StatWiseAI, an artificial intelligence-powered educational tool designed to enhance methodological rigor in the analysis of complex, large-scale datasets. The project, responding to RFA-DA-25-039: Education Activities for Responsible Analyses of...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $200,676 K23 Career Development Grant to the University of Wisconsin–Madison on September 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This five-year award supports the development of machine learning approaches to advance personalized smoking cessation risk prediction and intervention in adults attempting to quit smoking. The research leverages existing datasets from diverse adult...
- Federal Grant Award Summary Princeton University received a $164,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 15, 2025, with completion targeted for July 31, 2027. The award supports development of a Chemical Artificial Intelligence (AI) and Data Science Platform designed to identify and discover novel psychoactive substances (NPS). The project will deliver three primary products: (1) a...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $2,312,059 to the University of California, San Diego on August 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year project through April 30, 2030. This Project Grant funds implementation research and effectiveness testing of an integrated intervention designed to identify and engage sexual and gender minorities of color (SGMC) who are viremic and/or living with...
The National Institute on Drug Abuse (NIDA) awarded University of California, Irvine $235,500 under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and deploy an artificial intelligence-based chatbot designed to enhance engagement in mobile peer-to-peer support groups for smoking cessation. The project, initiated June 1, 2026, with completion targeted for April 30, 2029, involves refining an intelligent chatbot built on a state-of-the-art large language model trained on 77,400 historical support group posts. The chatbot will complement human support group members by responding to posts when peers are unavailable, ensuring consistent engagement through 25 response libraries containing over 1,000 evidence-based responses addressing smoking cessation support, nicotine replacement therapy assistance, coping strategies for cravings, and stress management. The primary deliverables include refinement of the chatbot using human-centered design methods through usability testing with 20 smokers across four focus groups, followed by field testing and deployment within actual mobile support groups. The intervention is grounded in the supportive accountability model of mobile health, leveraging a secure, locally-hosted server infrastructure with encrypted data storage to maintain participant privacy. By augmenting peer support with reliable AI-generated responses, the project aims to revitalize mobile health support group research, which has historically faced low engagement challenges, while simultaneously improving treatment adherence and outcomes for individuals seeking tobacco addiction cessation support.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $235.5k | 5/28/26 |